好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

TDP-43 cytoplasmic inclusion formation in C9orf72-associated FTLD/ALS
Aging, Dementia, and Behavioral Neurology
P1 - Poster Session 1 (5:30 PM-6:30 PM)
9-019
We compared TDP-43 neuronal cytoplasmic inclusions in post-mortem brain tissue from C9orf72-related frontotemporal lobar degeneration (FTLD)/ALS and sporadic FTLD/ALS. 

The G4C2 hexanucleotide repeat expansion (HRE) mutation in the C9orf72 gene is the most common genetic cause underlying both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Pathologically, these two neurodegenerative disorders are also linked by the common presence of abnormal TDP-43 neuronal cytoplasmic inclusions. However, the different characteristics of inclusion bodies in forebrains from patients dying with C9orf72-associated disease and sporadic disease brain have not been well studied.

We compared the number of TDP-43 inclusions, their morphology, and their immunohistochemical characteristics in post-mortem brain tissue from control, sporadic FTLD/ALS and C9orf72-associated FTLD/ALS. These comparisons were performed with an automated algorithm to quantitatively determine the abundance, size and morphological differences of TDP-43 inclusions between these groups. 

In sporadic FTLD/ALS, there were numerous TDP-43 inclusions that were variable in size, whereas inclusions in C9orf72 FTLD/ALS brain were less abundant and were smaller in size. TDP-43 immunostaining also differed between these two groups, with sporadic FTLD/ALS showing consolidated inclusions while C9orf72 showing more diffuse TDP-43 immunostaining in the neuronal cytoplasm. We were able to demonstrate these phenomena using multiple antibodies to confirm these differences in post-mortem brain tissues.  In addition, TDP-43 inclusions co-localized with autophagosome and lysosome markers, suggesting that TDP-43 inclusions are substrates for autophagic degradation. 

The smaller and less abundant TDP-43 inclusion bodies in C9orf72 FTLD/ALS compared to sporadic disease suggest differences in TDP-43 sequestration into inclusion bodies and degradation by autophagy which may have important pathophysiological implications for C9orf72-related diseases. 

Authors/Disclosures
Ming H. Lee, MD, PhD
PRESENTER
No disclosure on file
No disclosure on file
Chad Hales, MD, PhD, FAAN The institution of Dr. Hales has received research support from BrightFocus foundation. The institution of Dr. Hales has received research support from NIH. The institution of Dr. Hales has received research support from State of Georgia. Dr. Hales has a non-compensated relationship as a committee member with AAN that is relevant to AAN interests or activities.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Jonathan D. Glass, MD (Emory University School of Medicine) Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.